Login / Signup

Randomized phase II trial of chemoradiotherapy with S-1 versus combination chemotherapy with gemcitabine and S-1 as neoadjuvant treatment for resectable pancreatic cancer (JASPAC 04).

Teiichi SugiuraHirochika ToyamaAkira FukutomiHirofumi AsakuraYuriko TakedaKouji YamamotoSatoshi HiranoSohei SatoiIppei MatsumotoShinichiro TakahashiSoichiro MorinagaMakoto YoshidaYasunaru SakumaHidetaka IwamotoYasuhiro ShimizuKatsuhiko Uesaka
Published in: Journal of hepato-biliary-pancreatic sciences (2023)
Both NAC-RT with S-1 and NAC-GS are considered promising treatments for resectable pancreatic cancer.
Keyphrases
  • locally advanced
  • rectal cancer
  • squamous cell carcinoma
  • radiation therapy
  • transcription factor
  • open label
  • placebo controlled
  • double blind
  • phase iii
  • randomized controlled trial